Experimental Drug Might Help Some a Bit With Colon Cancer (HealthDay)
HealthDay – TUESDAY, Jan. 17 (HealthDay News) — The experimental cancer drug
regorafenib appears to extend survival slightly in patients with
metastatic colorectal cancer, a new trial indicates.